John Charin Somberg
#155,309
Most Influential Person Now
John Charin Somberg's AcademicInfluence.com Rankings
John Charin Sombergphilosophy Degrees
Philosophy
#8762
World Rank
#12202
Historical Rank
Logic
#5784
World Rank
#7218
Historical Rank

Download Badge
Philosophy
John Charin Somberg's Degrees
- Doctorate Medicine Stanford University
Why Is John Charin Somberg Influential?
(Suggest an Edit or Addition)John Charin Somberg's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- KCNE1 mutations cause Jervell and Lange-Nielsen syndrome (1997) (461)
- Genetic polymorphisms. (2002) (296)
- Neurocardiogenic Syncope (2009) (179)
- Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. (2002) (174)
- Biomarkers and surrogate endpoints. (1999) (119)
- Bioavailability and Pharmacokinetics of Magnesium After Administration of Magnesium Salts to Humans (2001) (108)
- Pharmacology and Pharmacokinetics of Amiodarone (1991) (99)
- Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. (1997) (95)
- QT prolongation and the antiarrhythmic efficacy of amiodarone. (1986) (81)
- Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. (2004) (76)
- The Drug Development Process (1988) (70)
- Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses. (1986) (68)
- The cimetidine-lidocaine interaction. (1983) (62)
- The arrhythmogenicity of antiarrhythmic agents. (1985) (60)
- QT interval dispersion in healthy subjects and survivors of sudden cardiac death: circadian variation in a twenty-four-hour assessment. (1997) (59)
- Localization of the neurally mediated arrhythmogenic properties of digitalis. (1979) (57)
- Usefulness of QT dispersion as an electrocardiographically derived index. (2002) (53)
- Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. (1986) (51)
- The Effects of Chiral Isolates of Methadone on the Cardiac Potassium Channel IKr (2008) (50)
- Influence of Electrolyte Abnormalities on Interlead Variability of Ventricular Repolarization Times in 12-Lead Electrocardiography (2001) (43)
- Withdrawal of propranolol and myocardial infarction. (1973) (42)
- Cibenzoline plasma concentration and antiarrhythmic effect (1984) (42)
- Effect of intracoronary balloon inflation at percutaneous transluminal coronary angioplasty on QT dispersion. (1998) (41)
- Myocardial infarction after propranolol withdrawal. (1974) (40)
- Role of the nervous system in the genesis of cardiac rhythm disorders. (1976) (38)
- Cardiovascular effects of nicotine: relation to deleterious effects of cigarette smoking. (1994) (36)
- First-in-Man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM trials. (2007) (35)
- Prolonged repolarization: a historical perspective. (1985) (34)
- Differential effect of glyburide (glibenclamide) and metformin on QT dispersion: a potential adenosine triphosphate sensitive K+ channel effect. (2002) (33)
- The Art of Drug Synthesis (2009) (32)
- The substrate and the trigger: the role of myocardial vulnerability in sudden cardiac death. (1987) (31)
- Pharmacological Perspectives of Toxic Chemicals and Their Antidotes (2006) (31)
- Pediatric drug development. (2003) (31)
- The antiarrhythmic effects of d-sotalol. (1987) (31)
- Alteration of the effects and distribution of ouabain by spinal cord transection in the cat. (1973) (31)
- Proarrhythmia: definition, risk factors, causes, treatment, and controversies. (1994) (30)
- Proarrhythmia of nonantiarrhythmic drugs. (1993) (29)
- Prolongation of QT interval and antiarrhythmic action of bepridil. (1985) (29)
- Antiarrhythmic effects of cibenzoline. (1985) (28)
- QT Prolongation and Serum Sotalol Concentration Are Highly Correlated following Intravenous and Oral Sotalol (2010) (26)
- The Clinical Pharmacology of Ethacrynic Acid (2009) (26)
- Gender Differences in Cardiac Repolarization Following Intravenous Sotalol Administration (2012) (26)
- Enhancement of Myocardial Vulnerability by Atrial Fibrillation (2004) (26)
- Localization of the Neurally Mediated Coronary Vasoconstrictor Properties of Digitalis in the Cat (1981) (25)
- Drug Delivery Systems (2004) (24)
- Effect of angiotensin-converting enzyme therapy on QT interval dispersion. (1999) (24)
- The Additive Effects of the Active Component of Grapefruit Juice (Naringenin) and Antiarrhythmic Drugs on HERG Inhibition (2007) (24)
- Flecainide: long-term treatment using a reduced dosing schedule. (1985) (23)
- Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone. (2002) (23)
- Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. (1986) (22)
- Developing a Safe Intravenous Sotalol Dosing Regimen (2010) (22)
- Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. (1984) (21)
- Differing sensitivities of Purkinje fibers and myocardium to inhibition of monovalent cation transport by digitalis. (1981) (20)
- Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. (1984) (20)
- The influence of prostaglandins E1 and E2 on ouabain cardiotoxicity in the cat. (1977) (20)
- Pharmacokinetics of Oral Cibenzoline in Arrhythmia Patients (1985) (20)
- Chiral Cardiovascular Drugs: An Overview (2005) (19)
- Adverse drug reaction reporting. (2000) (19)
- Comparative Effects of Rapid Bolus Administration of Aqueous Amiodarone Versus 10-Minute Cordarone I.V. Infusion on Mean Arterial Blood Pressure in Conscious Dogs (2004) (18)
- Neurally mediated augmentation of arrhythmogenic properties of highly polar cardiac glycosides. (1980) (18)
- New directions in antiarrhythmic drug therapy. (1984) (17)
- Martindale: The Complete Drug Reference (2005) (17)
- The Effect of High Extracellular Potassium on IKr Inhibition by Anti-Arrhythmic Agents (2006) (16)
- Assessment of cardiovascular and noncardiovascular medical device recalls. (2014) (16)
- Neural basis for the genesis and control of digitalis arrhythmias. (1976) (15)
- Supraventricular tachyarrhythmias: their evaluation and therapy. (1986) (15)
- Pharmacology and Toxicology of a New Aqueous Formulation of Intravenous Amiodarone (Amio-Aqueous) Compared with Cordarone IV (2005) (15)
- The pleiotropic effects of ethacrynic acid. (2009) (15)
- The Influence of Extracellular Acidosis on the Effect of IKr Blockers (2005) (15)
- The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog. (1984) (15)
- Retrospective Study on the Analgesic Activity of a Topical (TT-CTAC) Cream in Patients With Diabetic Neuropathy and Other Chronic Pain Conditions (2015) (15)
- Editorial: Deferred Consent: Issues In Clinical Research. (1995) (14)
- Digitalis: Historical Development in Clinical Medicine (1985) (14)
- Neural factors in digitalis toxicity: protective effect of C-1 spinal cord transection. (1978) (14)
- Evaluation of the Effects of Different Energy Drinks and Coffee on Endothelial Function. (2015) (14)
- A Mechanism for the Potential Proarrhythmic Effect of Acidosis, Bradycardia, and Hypokalemia on the Blockade of Human Ether-a-go-go-Related Gene (HERG) Channels (2005) (13)
- Refractory ventricular tachycardia with flecainide. (1986) (13)
- QT Dispersion: Still a Useful Measurement (2008) (13)
- Evaluation of a 12-Lead Digital Holter System for 24-Hour QT Interval Assessment (2006) (13)
- Bioterrorism and Infectious Agents (2006) (13)
- American Journal of Therapeutics. (2002) (13)
- Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events. (1991) (13)
- Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. (1987) (13)
- Studies on the possible mechanisms of lidoflazine arrhythmogenicity. (1984) (12)
- Sotalol versus Amiodarone in Treatment of Atrial Fibrillation. (2016) (12)
- A Guide to Methods in the Biomedical Sciences (2006) (12)
- Intravenous quinidine by intermittent bolus for electrophysiologic studies in patients with ventricular tachycardia. (1984) (12)
- Retrospective Evaluation on the Analgesic Activities of 2 Compounded Topical Creams and Voltaren Gel in Chronic Noncancer Pain (2015) (12)
- The management of acute heart failure and diuretic therapy. (2009) (12)
- Hypercalcemia, arrhythmia, and mood stabilizers. (2000) (12)
- Calcium channel blockers that prolong the QT interval. (1985) (12)
- Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis (2016) (12)
- Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. (1986) (12)
- Prophylactic tocainide or lidocaine in acute myocardial infarction. (1986) (11)
- Hypothyroidism Complicated by Angina Pectoris: Therapeutic Approaches (1992) (11)
- How the Immune System Recognizes Self and Nonself (2009) (11)
- Antiarrhythmic drug therapy. Recent advances and current status. (1985) (11)
- Flecainide: a new antiarrhythmic agent. (1986) (11)
- Blockade of tissue uptake of the antineoplastic agent, doxorubicin. (1978) (11)
- Flecainide toxicity. (1984) (10)
- Encainide: a new and potent antiarrhythmic. (1987) (10)
- The clinical significance of polymorphic ventricular tachycardia provoked at electrophysiologic testing. (1985) (10)
- To Begin Again (1994) (10)
- The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat. (1979) (10)
- Digitalis: Neurally Mediated Arrhythmogenic and Coronary Vasoconstrictor Properties (1985) (10)
- The Efficacy of Cibenzoline in Preventing PES Induction of Ventricular Tachycardia in the Dog (1984) (10)
- The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity. (1974) (9)
- Inhibitors of Protein Kinases and Protein Phosphatases (2005) (9)
- The influence of heart rate on ouabain cardiotoxicity in cats with spinal cord transection. (1978) (9)
- Extracellular Acidification and Hyperkalemia Induce Changes in HERG Inhibition by Ibutilide (2007) (9)
- Editorial: Inertia in Clinical Research. (1996) (9)
- Has the Promise Been Kept? (1992) (9)
- Histamine antagonists as antiarrhythmic agents in ouabain cardiotoxicity in the cat. (1980) (9)
- Retention of a Conditioned Avoidance Response after Metamorphosis in Mealworms (1970) (9)
- The treatment of ventricular rhythm disturbances. (1986) (8)
- Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. (1985) (8)
- Model-Informed Development of Sotalol Loading and Dose Escalation Employing an Intravenous Infusion (2020) (8)
- Ouabain cardiotoxicity, a reassessment of methodology. (1976) (7)
- Cell Surface Receptors: A Short Course on Theory & Methods (2006) (7)
- The Effect of Altered Renal Perfusion Pressure on Clearance of Digoxin (1980) (7)
- Drug Development Costs (1987) (7)
- Therapeutic approaches to the treatment of edema and ascites: the use of diuretics. (2009) (7)
- Research in emergency care without consent: new proposed FDA rules (1996) (7)
- Therapeutic approach to unstable angina: nitroglycerin, heparin, and combined therapy. (1993) (6)
- Verapamil — Digitalis interaction: Effect on cardiac Purkinje fibers and myocardium (1982) (6)
- Late stent thrombosis: problem or not? (2007) (6)
- The Effect of Magnesium Sulfate on Action Potential Duration and Cardiac Arrhythmias (2005) (6)
- Rapid Determination of Partition Coefficients Between n-Octanol/Water for Cardiovascular Therapies (2002) (6)
- Long-term lorcainide therapy in patients with ventricular tachycardia. (1985) (6)
- Effects of actodigin on the heart (1977) (6)
- Hypoxia and the Circulation (2009) (6)
- A choice, not an echo. (2000) (6)
- THE EVOLVING DRUG DISCOVERY AND DEVELOPMENT PROCESS (1996) (6)
- Lorcainide therapy for the high-risk patient post myocardial infarction. (1984) (5)
- Renal elimination of digoxin: studies with tritiated digoxin and radioimmunoassay. (1981) (5)
- Herbal-Drug Interactions and Adverse Effects (2004) (5)
- False‐Positive Urine Protein Reaction with Cibenzoline, a New Antiarrhythmic Agent (1984) (5)
- Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide. (1987) (5)
- The influence of propranolol on ouabain uptake by the guinea pig heart. (1973) (5)
- The effect of cimetidine administration on serum lidocaine levels in man (1982) (5)
- Molecular Mimicry: Infection-inducing Autoimmune Disease (2006) (5)
- Effect of quinidine on differing sensitivities of Purkinje fibers and myocardium to inhibition of monovalent cation transport by digitalis in dogs. (1983) (5)
- Treating and Preventing Obesity (2004) (5)
- Clinical Use of Class Ic Antiarrhythmic Drugs (1989) (5)
- The quest for an aqueous amiodarone. (2003) (5)
- Bioequivalence or Therapeutic Equivalence (1986) (5)
- The Merck Index Fourteenth Edition (2007) (5)
- Propafenone: a new antiarrhythmic agent. (1988) (5)
- Clinical Therapeutic Conference (1991) (5)
- Lorcainide therapy in a cardiac arrest population. (1986) (5)
- A comparison of actodigin and ouabain in cats. (1977) (4)
- Science, Politics and Hydroxychloroquine (2020) (4)
- Letter: The action of propranolol in man and animals. (1976) (4)
- Clinical trials registries. (2003) (4)
- Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. (1986) (4)
- Ventricular rhythm disorders and sudden cardiac death. (1976) (4)
- The report of the Institute of Medicine on drug safety. (2007) (4)
- Refractoriness as a determinant of tachycardia inducibility in the right ventricle. (1987) (4)
- The Calcium Channel Blockers. (1995) (4)
- THE EFFECT OF DIPHENIDOL ON OUABAIN CARDIOTOXICITY IN THE CAT (1978) (4)
- The effect of digoxin on the binding of adriamycin to cat heart muscle. (1977) (4)
- PROSTAGLANDIN E1 ELECTROPHYSIOLOGICAL SAFETY IN PATIENTS WITH CONGESTIVE HEART FAILURE AND PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (1997) (4)
- The midodrine withdrawal. (2010) (4)
- Antiarrhythmic action of bethanidine. (1984) (4)
- Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development (2004) (4)
- Amiodarone Therapy Guided by Electrophysiologic Testing: An Update (1991) (4)
- The pharmacologic treatment of heart failure. (2004) (3)
- The Role of Electrophysiologic Testing in the Selection of Amiodarone Therapy (1989) (3)
- Lithium, hypercalcemia, and arrhythmia. (1998) (3)
- A federal solution a regulation for all. (2000) (3)
- The influence of metiamide on ouabain cardiotoxicity. (1975) (3)
- Biomedical Devices and Their Applications (2006) (3)
- The Pace Quickens (1990) (3)
- The Clinical Implications of First‐Pass Metabolism: Treatment Strategies for the 1990s (1993) (3)
- Financing Technology’s Frontier (2004) (3)
- The Impact of Comorbidities on Stroke Prophylaxis Strategies in Atrial Fibrillation Patients (2011) (3)
- Van Nostrand??s Encyclopedia of Chemistry: Fifth Edition (2006) (3)
- Who is teaching pharmacology. (2004) (3)
- Reactions to Prescribed Drugs Kill Thousands Annually (1998) (3)
- GENDER DIFFERENCES IN DRUG THERAPY (1996) (3)
- Virtual Versus In-Person Learning as a Cardiologist During COVID-19 Pandemic (2020) (3)
- The human microbiome and therapeutics. (2012) (3)
- Device safety and effectiveness. (2010) (3)
- 67 PHARMACOLOGY AND TOXICOLOGY OF A NEW AQUEOUS FORMULATION OF INTRAVENOUS AMIODARONE (AMIO-AQUEOUS) IN COMPARISON TO CORDARONE IV (2005) (3)
- A comparison of the in vivo and in vitro actions of ouabain to produce cardiac arrhythmia. (1974) (3)
- A randomized comparative study of the electrophysiological and electrocardiographic effects of isradipine vs verapamil (1993) (3)
- Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia. (1984) (3)
- Control of Cardiac Rhythm (1998) (3)
- A challenge to America. (2001) (3)
- The Evaluation of the Diuretic Action of Parenteral Formulations of Metolazone (2007) (3)
- The Clinical Therapeutic Conference (1991) (3)
- Evaluation of Dosing Interval and Optimum Dose of Cibenzoline (1987) (3)
- Digitalis: 200 years in perspective. (1986) (3)
- Localization of neurally mediated arrhythmogenic and coronary vasoconstrictor properties of digitalis. (1984) (3)
- The Central Institutional Review Board (1999) (2)
- The failing Ebola policy. (2014) (2)
- Adverse Reactions of Amiodarone on the Thyroid (2016) (2)
- Inhibition of Human Ether-A-Go-Go-Related Gene (hERG) Potassium Current by the Novel Sotalol Analogue, Soestalol. (2020) (2)
- Who's Practicing Medicine (1990) (2)
- Habituation of Mealworm Pupae, Tenebrio molitor, (1973) (2)
- Lesson to be learned from the renal denervation trials. (2015) (2)
- A Rapid Method to Evaluate Cardiac Repolarization Changes: The Effect of Two Coffee Strengths on the QT Interval (2015) (2)
- Digitalis: Its Place in Therapy (1985) (2)
- Patent foramen ovale closure devices: thoughts from the circulatory device advisory panel. (2007) (2)
- Comparative Efficacy of Pirmenol and Procainamide in a Drug‐Resistant Population with Ventricular Tachycardia (1987) (2)
- The Pharmaceutical Revolution: Drug Discovery and Development (2006) (2)
- Risk Factors Not Addressed in Antihypertensive Therapy Based Solely on Blood Pressure Control (1993) (2)
- The new year. (2015) (2)
- Free exchange of ideas. (2003) (2)
- New Approaches to Drug Selection and Serial Drug Testing (1984) (2)
- Digoxin therapy for atrial fibrillation in the twenty-first century. (2014) (2)
- Harrison??s Principles of Internal Medicine (2005) (2)
- The Therapeutics of Hypertensive Emergency. (1996) (2)
- Introduction to Drug Discovery and Development (2019) (2)
- Cardiovascular drug development : protocol design and methodology (1999) (2)
- Esmolol: A Novel Ultra‐short‐Acting Beta‐Blocking Agent (1986) (2)
- Unfinished business in health care reform. (2011) (2)
- Antiarrhythmic effects of indecainide in a drug-resistant population with ventricular tachycardia at programmed electrical stimulation. (1987) (2)
- In Memoriam: Duncan Elliot Hutcheon June 1922–February 2010 (2010) (2)
- Biomarker and surrogate endpoints. (2003) (2)
- Ethmozine Toxicity: Fever of Unknown Origin (1986) (2)
- Clinical therapeutic conference: congestive heart failure therapy. (2001) (2)
- The heart vector, the regional information in the electrocardiogram, and QT dispersion: Reply (2002) (2)
- The Dynamics of QT Dispersion (2009) (2)
- The Dark Side of Implantable Cardioverter Defibrillator Therapy (2013) (2)
- The Differential Antibacterial and Gastrointestinal Effects of Erythromycin and Its Chiral Isolates (2006) (2)
- Mild heart failure: why the switch to ACE inhibitors? (1993) (2)
- Introduction: Digitalis and Newer Inotropic Agents (1985) (1)
- Topics in clinical pharmacology: cardiovascular and diabetes mellitus. (2010) (1)
- The Spectrum of CAST I and II (1991) (1)
- Class effects of pharmaceuticals and therapeutic interchangeability. (2001) (1)
- The Drug Development Process and Clinical Practice (1990) (1)
- Securing the US pharmaceutical supply. (2008) (1)
- Reorganizing the flow of scientific information: is the age of electronic journalism here? (1999) (1)
- Are we overregulated? (2001) (1)
- International symposium on drug development. (1999) (1)
- Are We on Course? (1992) (1)
- The CAST Results (1990) (1)
- Clinical Pharmacology Teaching (1987) (1)
- Clinical Trials Methodology (2019) (1)
- N-Acetylprocainamide's Antiarrhythmic Action in Patients with Ventricular Tachycardia (1986) (1)
- New directions in antiarrhythmic drug therapy: the development of a promising new agent, lorcainide. (1984) (1)
- A new therapeutic millennium [correction of millenium]. (2001) (1)
- Van Gogh and Digitalis. (2020) (1)
- The Food and Drug Administration Commissioner (1990) (1)
- Atrial fibrillation and valve disease. (2002) (1)
- Lessons From the Frontiers (1991) (1)
- Successful heart failure therapy is effective antiarrhythmia therapy. (1996) (1)
- Evaluating Serious Adverse Drug Reactions (2018) (1)
- New FDA Initiatives (1993) (1)
- Therapy for Late Post Infarction Ventricular Tachycardia (1985) (1)
- Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual. (1978) (1)
- Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane Oxygenation (2019) (1)
- Risk assessment, drug approval, and liability. (2006) (1)
- The Bretylium Saga: A Novel "Old Drug" for Cardiac Resuscitation. (2020) (1)
- Is there an imperative for generic profiling to hasten the age of personalized medicine. (2012) (1)
- A Practical Guide to Food and Drug Law and Regulation FDLI (2009) (1)
- USE OF DUAL ANTIPLATELET VERSUS SINGLE ANTIPLATELET THERAPY FOR PREVENTION OF RECURRENT ISCHEMIC STROKE: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2015) (1)
- Drug trial registries. (2004) (1)
- Centralized Drug Development (1992) (1)
- Proarrhythmia or Arrhythmogenicity. (1995) (1)
- A case of herceptin cardiotoxicity. (2004) (1)
- Nesiritide: the wrong controversy. (2005) (1)
- Flecainide: Safety and Efficacy (2008) (1)
- Lessons learned from the COX-2 advisory hearings. (2005) (1)
- Antiarrhythmic drugs: making sense of the deluge. (1987) (1)
- Supporting therapeutic innovation. (2009) (1)
- Regulating Continuing Medical Education (1993) (1)
- The Need for Stimulation. (2015) (1)
- Guidelines for a new year. (2014) (1)
- The Food and Drug Administration's paternalism. (2010) (1)
- My Data, Your Data, Whose Data? (1990) (1)
- The extrapolation of study results in the device approval process. (2009) (1)
- Neurocardiogenic syncope with Addison's disease. (2000) (1)
- Health care reform. (2009) (0)
- APPROACHES TO INTRAVENOUS NITROGLYCERIN THERAPY (1996) (0)
- New advances and new questions in cardiovascular therapeutics. (2009) (0)
- 21 EFFICACY OF LIDOCAINE AND A NEW AQUEOUS FORMULATION OF AMIODARONE IN THE TERMINATION OF SUSTAINED VENTRICULAR TACHYCARDIA. (2004) (0)
- An Introduction to Human Genetics (2006) (0)
- Medical isotope shortages. (2009) (0)
- Is the device development process adequate. (2010) (0)
- Guidelines or 10 commandments. (2012) (0)
- A milestone in clinical pharmacology. (1996) (0)
- On Stronger Footing (1992) (0)
- Drug and device trials: should we ask more. (2011) (0)
- Rheumatology & Immunology Therapy (2005) (0)
- ACADEMIC JOURNALISM IN AMERICA (1997) (0)
- To Board or Not (1992) (0)
- The effect of opening coronary occlusion on QT dispersion (1998) (0)
- Has the food and drug administration changed the drug approval process? (2011) (0)
- The American College of Clinical Pharmacology in the Future (1989) (0)
- PERSONAL RESPONSIBILITY OR GOVERNMENT FIAT (1999) (0)
- About this journal. (2012) (0)
- Harold Neu: In Memoriam (1998) (0)
- The effect of quinidine and quinine on a potassium current (IKr) (2001) (0)
- Does IV metolazone potentiate the diuretic action of IV furosemide (2001) (0)
- Nonphysician Prescribing. (1996) (0)
- Abstract 3703: The Effect of Naringenin and Antiarrhythmic Drugs on IKr Inhibition (2006) (0)
- We Need More COVID Therapies (2023) (0)
- DRUGS FOR ARRHYTHMIAS (1975) (0)
- QT measurements following ace therapy (2003) (0)
- Dismantling the FDA. (1995) (0)
- Old drugs, new bottles, therapeutic advantage? (2002) (0)
- The Scope of Clinical Pharmacology (1990) (0)
- The Supremes got it right. (2013) (0)
- 82 INHIBITION OF THE HERG CHANNEL BY ASPIRIN: PH OR DIRECT EFFECT? (2007) (0)
- The College in Change (1991) (0)
- Sudden death in athletes. (2000) (0)
- Abstract 17174: Revisiting the QT Correction Formulas: A Generalized Additive Models for Location, Scale, and Shape Approach (2020) (0)
- Mandatory post marketing studies. (2007) (0)
- The College and its Awards (1991) (0)
- Rational therapeutics: dose titration and monotherapy in clinical practice. (1996) (0)
- THE GOVERNMENTAL REVOLUTION (1995) (0)
- THERAPEUTIC CASE REPORTS (1997) (0)
- A Comparison of Tablets with Oral Suspension Formulation of Dipyridamole in Thallium Myocardial Imaging (1992) (0)
- Current Opinions on the Trajectory of the Pharmaceutical Development (2019) (0)
- THOMAS W. SMITH (1997) (0)
- Welcome to the Annual Meeting (1993) (0)
- Long term lorcainide therapy guided by electrophysiology studies. (1985) (0)
- Drug Classification and Actions (1991) (0)
- 68 CHIRAL SEPARATION OF THE INOTROPIC AND CHRONOTROPIC ACTIONS OF DIGOXIN (2005) (0)
- 58 THE EFFECTS OF QUINIDINE AND ITS CHIRAL ISOLATES ON ERG-1SM POTASSIUM CURRENTS AND CORRELATION WITH GASTROINTESTINAL AUGMENTATION. (2006) (0)
- The conflict of interest charade. (2013) (0)
- Have we maxed out on new therapies. (2011) (0)
- Drugs and the Liver (2010) (0)
- B2 agonist inhalation increases QTc dispersion (1998) (0)
- Clinical Pharmacology: Medicine or Pharmacology (1992) (0)
- Arrhythmia therapy. (2002) (0)
- From therapeutic nihilism to therapeutic success. (2011) (0)
- Drugs From Discovery to Approval (2004) (0)
- Therapeutics, drug pricing and innovation. (2003) (0)
- 14 COMPARATIVE EFFECTS OF RAPID BOLUS ADMINISTRATION OF AQUEOUS AMIODARONE VERSUS 10-MINUTE CORDARONE IV INFUSION ON MEAN ARTERIAL BLOOD PRESSURE IN CONSCIOUS DOGS (2005) (0)
- Letter: Drugs for arrhythmias. (1975) (0)
- Subject Index, Vol. 72, 1985 (1985) (0)
- The influence of extracellular acidosis on the effect of Type III antiarrhythmic agents on the cardiac potassium channel (IKr) (2006) (0)
- Should statins go OTC. (2004) (0)
- Immunological Aspects of Neoplasm - The Role of the Thymus (2005) (0)
- 67 EVALUATION OF A 12-LEAD DIGITAL HOLTER SYSTEM FOR 24-HOUR Q-T INTERVAL ASSESSMENT. (2006) (0)
- Pharmacotherapy: A Pathophysiologic Approach (2007) (0)
- Amiodarone Challenges the Clinical Pharmacologist (1989) (0)
- Making America more competitive: a paradigm shift in drug and device development. (2012) (0)
- Drug Delivery System (1989) (0)
- Proposed product labeling changes: does it really matter? (2001) (0)
- Defining A Journal (1993) (0)
- Managing heart failure patients with ACE inhibitors (1997) (0)
- Stanley Gottlieb, MD, 1929-2007 (2007) (0)
- Hypertension therapeutics in turmoil. (2003) (0)
- Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory process. (1999) (0)
- Stem-cell research. (2001) (0)
- Inappropriate attack on device development. (2011) (0)
- Are we facilitating therapeutic innovation? (2011) (0)
- Therapeutic hangups. (2008) (0)
- Biological Basis of Geriatric Oncology (2005) (0)
- Drug Discovery and Development (2019) (0)
- Heart rate variability / QT-dispersion 29 245 Altered RR Interval dynamics and vulnerability to life-threatening arrhythmias : fractal analysis (2004) (0)
- 807-5 Extracellular pH modifies drug blockade on the human ether-A-go-go related gene (HERG) channels (2004) (0)
- What's gone wrong with clinical research. (2000) (0)
- Non‐Approved Indications (1990) (0)
- Biomarker Methods in Drug Discovery and Development (2009) (0)
- Ic Antiarrhythmic Drugs (1989) (0)
- Subject Index Vol. 106, 2006 (2006) (0)
- Contents, Vol. 72, 1985 (1985) (0)
- The Spectrum of CAST I and II (1991) (0)
- Abstract 3596: The Effect of Chiral Isolates of Digoxin on Systemic Vascular Resistance (2006) (0)
- THE FOURTH INTERNATIONAL SYMPOSIUM ON CARDIOVASCULAR DRUG DEVELOPMENT Developing Drugs for Ischemic Heart Disease (1995) (0)
- Usefulness of electrophysiologic studies in predicting drug efficacy in patients receiving amiodarone. (1987) (0)
- Corrected ethmozine dosage (1986) (0)
- Sharing Regulatory Review Costs (1992) (0)
- Symposium Introduction (1984) (0)
- The Need for Randomized Clinical Trials (2007) (0)
- CLINICAL THERAPEUTIC CONFERENCE: Therapeutic Considerations in Atrial Fibrillation Management (1996) (0)
- A Symposium on Alpha Blockade (1993) (0)
- OUS results, clinical studies and therapeutic innovation in America. (2014) (0)
- The American College of Clinical Pharmacology: Challenges of the 90s (1990) (0)
- Abstract 11416: The Effect of Deep Brain Stimulation on Autonomic Dysfunction in Parkinson Disease (2012) (0)
- Physician specific prescribing information. (2006) (0)
- Pharmacoeconomics: These Changing Times. (1994) (0)
- Signing Off (2015) (0)
- 20 VENOUS IRRITATION WITH CORDARONE IV AND TWO DIFFERENT FORMULATIONS OF AQUEOUS AMIODARONE WHEN ADMINISTERED VIA PERIPHERAL VEINS. (2004) (0)
- Smoking, Smoking Cessation, and Regulation. (1996) (0)
- Let Us Do Not Forget Durability (2020) (0)
- Do We Serve a Need (2021) (0)
- Conflicts of Interest and “Nothing to Disclose” (2011) (0)
- FDA Commissioner's Confirmation Hearings (1998) (0)
- MISOPROSTOL AND EICOSANOIDS: A NEW AND EXCITING AREA OF THERAPEUTICS (1995) (0)
- Therapies for COVID-19: A Disorganized Approach (2021) (0)
- Big Science Little Science: Science in Controversy (1993) (0)
- 93 CHIRAL SEPARATION OF THE INOTROPIC AND CHRONOTROPIC ACTIONS OF DIGOXIN IN A CANINE MODEL. (2007) (0)
- Abstract 11063: Evaluation of Different Energy Drinks and Coffee on Endothelial Function (2015) (0)
- Ventricular Repolarization Spectra (2008) (0)
- PRACTICE GUIDELINES, CONSENSUS CONFERENCES: THE PROS AND CONS (1995) (0)
- The Educational Process (1991) (0)
- The Importance of Cardiology Research (2020) (0)
- This Past Year in Research (2021) (0)
- Computerization in medicine. (2015) (0)
- Habituation Of Mealworm Pupae, Tenebio-Molitor Coleoptera-Tenebrionidae (1973) (0)
- Abstract 15024: Efficacy of Bretylium in Termination of Treatment Resistant Ventricular Tachycardia and Ventricular Fibrillation (2020) (0)
- The Clinician Scientist (1998) (0)
- A Milestone in Clinical Pharmacology (1991) (0)
- Examination for Board Certification (1990) (0)
- In Memoriam: Dr. James Black 1934–2010 (2010) (0)
- The cholesterol hypothesis: questioned? (2008) (0)
- Let Us Aggressively Confront the Coronavirus Pandemic (2020) (0)
- The cart before the horse. (2013) (0)
- THE FIFTH INTERNATIONAL SYMPOSIUM ON CARDIOVASCULAR DRUG DEVELOPMENT THE US REGULATORY PROCESS ADVANCES IN CARDIOVASCULAR PHARMACOLOGY: PROTOCOL DESIGN & METHODOLOGY (1995) (0)
- The Journal's Development (1987) (0)
- The stimulus package and medical therapeutics. (2009) (0)
- Thrombolytic Therapy: A Drug Approvability Controversy (1987) (0)
- The provisional approval step. (2005) (0)
- Industry Under Siege (1993) (0)
- Pharmaceutical Costs (1992) (0)
- Intravenous nitroglycerin causing heparin resistance (1996) (0)
- The QT Interval in Research (2021) (0)
- Thoughts on Drug Development (1992) (0)
- Off-label promotion. (2006) (0)
- Heart Failure Research and Polypharmacy (2022) (0)
- Evidence based or mechanism based therapeutics. (2009) (0)
- The sins of ghostwriting. (2008) (0)
- HOLD THAT PATENT (1997) (0)
- The drug eluting stent challenge. (2008) (0)
- Composite end points, black box warnings, and allegations of bias. (2010) (0)
- Licensing to prescribe. (2008) (0)
- FDA user fees and innovation. (2008) (0)
- Guilt by association. (2007) (0)
- Drug shortages and ensuring the U.S. supply of needed pharmaceuticals. (2012) (0)
- Acquired Long QT Syndrome (2007) (0)
- Contents Vol. 106, 2006 (2006) (0)
- Antiarrhythmic Drug Therapy: A Continuously Evolving Field (1991) (0)
- A perspective on the support of scientific research. (2013) (0)
- The Direction of the ACCP (1993) (0)
- The influence of liver injury on the distribution of digitoxin in the rat. (1974) (0)
- Letter from Konstantinos P. Letsas et al. – Invited Editorial Comment (2006) (0)
- The Cancer Myth. (1996) (0)
- The Electronic Abstract System (2006) (0)
- Physicians in Industry (1992) (0)
- 7 BLOCKADE OF HUMAN ETHER-A-GO-GO RELATED GENE (HERG) CHANNELS BY QUINIDINE. (2004) (0)
- Editorial: Therapeutics, Clinical Phamacology, Molecular Pharmacology: Have We Lost Our Academic Way? (1994) (0)
- 10 THE DIFFERENTIAL EFFECTS OF ERYTHROMYCIN AND ITS CHIRAL ISOLATES ON GASTROINTESTINAL MOTILITY. (2004) (0)
- Letter regarding articles by Kereiakes and Willerson, Mehran et al, and Kaplan et al, "mini-review: expert opinion". (2005) (0)
- New Therapy update (1986) (0)
- A comparison of IV adenosine vs. Oral dipyridamole in thallium imaging (1991) (0)
- Drug Discovery: A History (2006) (0)
- Venous irritation with Cordarone IV and two different formulations of Aqueous Amiodarone (2004) (0)
- Genetic drug targeting. (2006) (0)
- Branded Generics (1993) (0)
- The hypertension peril and drug development. (2007) (0)
- Digitoxin blockade of adriamycin cardiotoxicity in the rabbit (1982) (0)
- Panel discussion (1995) (0)
- Clinical Pharmacology of Therapeutic Proteins (2007) (0)
- Clinical Therapeutic Conference: Sudden Death in a Young Athlete. (1995) (0)
- Branded generics. (1993) (0)
- The Regulatory Process (1986) (0)
- Obesity therapeutics in the shadows: editorial. (2004) (0)
- 1154-97 Electrocardiogram morphology predictors of pharmacologic termination of ventricular tachycardia (2004) (0)
- 68 THE EFFECT OF ACIDOSIS AND HYPERKALEMIA ON THE IKr BLOCKING ACTION OF ANTIARRHYTHMIC DRUGS. (2006) (0)
- Screening drugs for QT prolongation. (2007) (0)
- Pharmaceutical companies and medical therapeutics education. (2006) (0)
- Editorial: The Basis of Pharmaceutical Approval. (1994) (0)
- Smoking Cessation Strategies. (1996) (0)
- Drug Development and Patient Benefit (1991) (0)
- Milestones for the College (1990) (0)
- Clinical Pharmacology Programs (2002) (0)
- Approach to chest pain: noncardiac and angina. Foreword. (2008) (0)
- CHANGING THE REGULATORY PROCESS (1996) (0)
- Clinical research oversight. (2002) (0)
- 69 THE EFFECT OF NARINGENIN (GRAPEFRUIT JUICE) AND ANTIARRHYTHMIC DRUGS ON IKr INHIBITION. (2006) (0)
- The Pendulum Swings (1992) (0)
- Do we need to accredit clinical research? (2001) (0)
- Angiotensin-Neprilysin Combinations Marketing Poly or Therapeutic Optimization. (2015) (0)
- The device development pinata. (2011) (0)
- Let us regulate pharmaceuticals: here we go again. (2015) (0)
- Off Label Indications. (1995) (0)
- The Drug Development Conundrum (1991) (0)
- Pediatric exclusivity and genericizing pharmaceuticals. (2001) (0)
- An Invitation From the New Editors (1985) (0)
- Abstract 12650: A Faster and Safe Way for Dose Escalation of Sotalol Therapy in Patients With Atrial Fibrillation or Flutter (2020) (0)
- Is clinical research oversight adequate in the United States? (2000) (0)
- Restricting physician prescribing. (2002) (0)
- Clinical Therapeutic Conference (1992) (0)
- Intellectual property. (2005) (0)
- The hubris of science: defending the scientific process from political agendas. (2010) (0)
- Abstract 11403: Medical Device Recalls in the U.S (2012) (0)
- The Information Age and Therapeutics. (1995) (0)
- Surrogate endpoints and drug approval. (2006) (0)
- 83 IS THE PH-INDUCED CHANGE IN IKR INHIBITION BY IBUTILIDE ARRHYTHMOGENIC? (2007) (0)
- Clinical Therapeutic Conference: Thyroid Hormone Replacement in Hypothyroidism. (1995) (0)
- 2 VENOUS IRRITATION WITH CORDARONE IV AND TWO DIFFERENT FORMULATIONS OF AQUEOUS AMIODARONE WHEN ADMINISTERED VIA PERIPHERAL VEINS (2004) (0)
- The Research Covenant (2003) (0)
- An opportunity to distance the FDA from Washington politics. (2005) (0)
- The politics of therapeutics. (2004) (0)
- Is the evidence right in evidence-based practice? (2000) (0)
- A Year of Participation (1991) (0)
- Treatment of Psoriasis (2009) (0)
- REVISITING ADVERSE DRUG REACTIONS (1996) (0)
- SARS challenges therapeutics. (2003) (0)
- Thoughts from the Editor (1992) (0)
- Biologic problems. (2002) (0)
- The generic conundrum. (2002) (0)
- Can nitroglycerin convert effort-induced angina in men into silent myocardial ischemia? (1995) (0)
- Therapeutics 2004. (2004) (0)
- Proposed accelerated FDA approvals for special medical use. (2012) (0)
- Publication Phobias (1993) (0)
- Biologic generics. (2007) (0)
- Contents Vol. 124, 2013 (2013) (0)
- Courts, patents, litigation & patient care. (2014) (0)
- Do We Serve a Need? (2021) (0)
- What is a journal. (2004) (0)
- Clinical trials and their surprises. (2014) (0)
- The Promise of Chirality. (1995) (0)
- Clinical Therapeutic Conference: Vancomycin Nephrotoxicity. (1994) (0)
- THE YEAR IN REVIEW (1996) (0)
- Medical judgment and therapeutics. (1999) (0)
- The Anonymity of Drug Development (1986) (0)
- What is New in Pharmacologic Therapy for Cardiac Resuscitation? (2020) (0)
- Abstract 12649: A Faster and Safe Way to Initiate Sotalol Therapy for Patients With Atrial Fibrillation or Flutter (2020) (0)
- 1108 – STUDIES ON THE TOXICITY OF A CHARGED DIGITALIS DERIVATIVE (1978) (0)
- 52 THE INFLUENCE OF EXTRACELLULAR ACIDOSIS ON THE EFFECT OF ANTI-ARRHYTHMIC AGENTS ON THE CARDIAC POTASSIUM CHANNEL (IKr) (2005) (0)
- The Need To Know (1985) (0)
- Health care in turmoil. (2013) (0)
- The Tension Builds (1993) (0)
- A New Leadership (1990) (0)
- Conflating the approval process and clinical research with pharmacoeconomic evaluation. (2013) (0)
- Bioterrorism 2002. (2002) (0)
- A NEW VIRUS AND THE ADEQUACY OF PUBLIC HEALTH METHODS (1995) (0)
- The long acting antiarrhythmic properties ot a B-halo alkyi derivative of lidocaine (1990) (0)
- Preclinical Development Handbook: Toxicology (2009) (0)
- New Antibiotic Targets (2009) (0)
- HISTAMINE AND ANTIHISTAMINES: CLINICAL PHARMACOLOGY FOR THE PRACTICING PHYSICIAN (1996) (0)
- On the QT (2021) (0)
- The new drug evaluation process: risk benefit ratio. (2005) (0)
- Proceedings of the nineteenth annual symposium: advances in cardiovascular pharmacology: protocol design and methodology. the U.S. Regulatory Process. May 3, 4, 5, 2000, Washington, D.C. (2001) (0)
- THE FDA and SOFTWARE (1996) (0)
- Frontiers in Cardiology Research (2020) (0)
- The cost of therapy. (2000) (0)
- The drug safety review process. (2007) (0)
- United States Patent ( 19 ) Ehrenpreis et al . 54 PARENTERAL SOLUTIONS CONTAINING AMODARONE IN ACETATE BUFFER SOLUTION (2017) (0)
- International vs. hospital acquired infection. (2014) (0)
- Acknowledgement to the Reviewers (2006) (0)
- THE COMMERCIALIZATION OF RESEARCH (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John Charin Somberg?
John Charin Somberg is affiliated with the following schools: